CME Group Inc (NASDAQ: CME) is 2.71% higher on its value in year-to-date trading and has touched a low of $190.70 and a high of $222.63 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CME stock was last observed hovering at around $218.18 in the last trading session, with the day’s loss setting it -1.88%.
Currently trading at $216.30, the stock is 0.71% and 4.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.73 million and changing -0.86% at the moment leaves the stock 4.22% off its SMA200. CME registered 7.34% gain for a year compared to 6-month loss of -0.03%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 3.56% gain in the last 1 month and extending the period to 3 months gives it a 10.06%, and is -1.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.53% over the week and 1.44% over the month.
CME Group Inc (CME) has around 3565 employees, a market worth around $77.89B and $5.80B in sales. Current P/E ratio is 23.86 and Fwd P/E is 21.52. Profit margin for the company is 56.26%. Distance from 52-week low is 13.42% and -2.84% from its 52-week high. The company has generated returns on investments over the last 12 months (10.63%).
The EPS is expected to grow by 6.43% this year
1881.0 institutions hold shares in CME Group Inc (CME), with institutional investors hold 90.06% of the company’s shares. The shares outstanding are 359.23M, and float is at 358.90M with Short Float at 1.08%. Institutions hold 89.67% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 33.57 million shares valued at $6.6 billion. The investor’s holdings represent 9.344 of the CME Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 25.66 million shares valued at $5.05 billion to account for 7.1435 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.02 million shares representing 4.4585 and valued at over $3.15 billion, while CAPITAL WORLD INVESTORS holds 3.44 of the shares totaling 12.36 million with a market value of $2.43 billion.
CME Group Inc (CME) Insider Activity
The most recent transaction is an insider sale by Fitzpatrick Lynne, the company’s Sr MD Chief Financial Officer. SEC filings show that Fitzpatrick Lynne sold 754 shares of the company’s common stock on Sep 15 ’24 at a price of $216.99 per share for a total of $0.16 million. Following the sale, the insider now owns 13261.0 shares.
CME Group Inc disclosed in a document filed with the SEC on Aug 30 ’24 that Durkin Bryan T (Director) sold a total of 7,593 shares of the company’s common stock. The trade occurred on Aug 30 ’24 and was made at $214.59 per share for $1.63 million. Following the transaction, the insider now directly holds 55607.0 shares of the CME stock.
Still, SEC filings show that on Aug 30 ’24, Durkin Bryan T (Officer) Proposed Sale 7,593 shares at an average price of $213.52 for $1.62 million. The insider now directly holds shares of CME Group Inc (CME).
